Of Pens, Pizzas, and Pharmaceuticals.
- Published in:
- 2016
- By:
- Publication type:
- Opinion
Works matching IS 14628732 AND DT 2016 AND VI 22 AND IP 2
Results: 9
1
2
The BIEM Verification Study: Experienced Venture Capitalists Assess a Biopharmaceuticals Innovation Expertise Model.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 2, p. 50, doi. 10.5912/jcb749
- By:
- Publication type:
- Article
3
Technology Commercialization & Partnerships for Global Health - Drugs, Vaccines and Medical Devices.
- Published in:
- 2016
- By:
- Publication type:
- Proceeding
4
Investor Experience in Biotechnology.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 2, p. 34, doi. 10.5912/jcb742
- By:
- Publication type:
- Article
5
The Chinese Medical Device Market: Market Drivers and Investment Prospects.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 2, p. 27, doi. 10.5912/jcb741
- By:
- Publication type:
- Article
6
Post-Grant Review of U.S. Patents: A Primer.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 2, p. 69, doi. 10.5912/jcb738
- By:
- Publication type:
- Article
7
Manage Complexity and Uncertainty in Biotechnological Innovations: Converting Theoretical Advances Into Opportunities.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 2, p. 19, doi. 10.5912/jcb737
- By:
- Publication type:
- Article
8
Intellectual Property Business Models Using Patent Acquisition: A Case Study of Royalty Pharma Inc.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
9
Recent Developments in Compulsory Licensing of Pharmaceutical Patents in India.
- Published in:
- Journal of Commercial Biotechnology, 2016, v. 22, n. 2, p. 64, doi. 10.5912/jcb733
- By:
- Publication type:
- Article